Focus on Infectious Disease
  • Saved
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates - PubMed

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36516269/

Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent...



Protective immunity was achieved within 7 days of vaccination and was maintained through 1 year after vaccination. Antigen-specific antibodies were an immune correlate of protection in the acute challenge model, and their concentration was predictive of protection. These results demonstrate that a single-shot ChAd3-MARV vaccine generated a...

  • Saved
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants

Source : https://doi.org/10.1101/2023.01.02.23284120

As the COVID-19 pandemic continues, long-term immunity against SARS-CoV-2 will be globally important. Official weekly cases have not dropped below 2 million since September of 2020, and continued emergence of...



These results indicate that anti-SARS-CoV-2 antibody responses undergo continual maturation following primary exposure by either vaccination or infection for at least 400 days after last antigen exposure. We show that neutralizing antibody responses improved upon secondary boosting with greater impact seen after extended intervals. Our findings...

  • Saved



Highlights:
• Children have diverse polyclonal SARS-CoV-2-specific naïve T cells.
• Adults have clonally expanded exhausted SARS-CoV-2-specific memory T cells.
• Interferon-activated naïve T cells differentiate into memory T cells in adults but not children.
• Adults but not children develop robust memory T cell responses to...

  • Saved
False-Positive Human Immunodeficiency Virus Results in COVID-19 Patients

False-Positive Human Immunodeficiency Virus Results in COVID-19 Patients

Source : https://www.cureus.com/articles/130820-false-positive-human-immunodeficiency-virus-results-in-covid-19-patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which causes coronavirus disease 2019 (COVID-19) disease, was first described in 2019 and became a pandemic in 2020. Although it is...



HIV-1 gp41 and SARS-CoV-2 share several structural sequences and motifs. These similarities could explain cross-reactivity and false-positive results when screening for HIV in the presence of COVID. The presence of HIV must be confirmed through more specific laboratory tests such as ELISA.

  • 3yr
    reported 7.2% of COVID-19 cases are associated with other bacterial, fungal, or viral pathogens, which may affect survival rates and treatment options
  • Saved
Amiodarone for the Treatment of Arrhythmias in COVID-19 Patients Does Not Increase the Risk of Pulmonary Fibrosis: A Retrospective Cohort Study

Amiodarone for the Treatment of Arrhythmias in COVID-19 Patients Does Not Increase the Risk of Pulmonary Fibrosis: A Retrospective Cohort Study

Source : https://www.cureus.com/articles/133667-amiodarone-for-the-treatment-of-arrhythmias-in-covid-19-patients-does-not-increase-the-risk-of-pulmonary-fibrosis-a-retrospective-cohort-study

Amiodarone is a class III antiarrhythmic medication used to treat atrial and ventricular tachyarrhythmias. Pulmonary fibrosis from amiodarone use is a well-documented side effect. Pre-COVID-19 pandemic studies have shown that...



The clinical factors associated with the development of pulmonary fibrosis in both groups included a history of preexisting interstitial lung disease (ILD) (p=0.001), exposure to prior radiation therapy (p=0.021), and higher severity of COVID-19 illness (p

  • 3yr
    Amiodarone is a class III antiarrhythmic medication utilized in the rhythm control of both atrial and ventricular tachyarrhythmias. Its mechanism works to prolong the action potential duration by blocking potassium Show More